Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/11/2025

Management of Biventricular Hypertrophy

Diagnostic Evaluation

  • Comprehensive cardiac imaging with echocardiography is essential to confirm biventricular hypertrophy, assess the degree of obstruction, and evaluate for associated abnormalities such as mitral valve dysfunction 2, 3
  • Cardiac MRI should be considered to better characterize the extent of hypertrophy, detect fibrosis, and assess for iron overload, particularly in cases with unclear diagnosis 1, 2
  • Electrocardiographic monitoring is recommended to detect conduction abnormalities and arrhythmias, which are common complications 1, 4

Medical Management

  • Non-vasodilating beta-blockers titrated to maximum tolerated dose are the first-line treatment for symptomatic biventricular hypertrophy, particularly when left ventricular outflow tract obstruction (LVOTO) is present 4, 5
  • Calcium channel blockers (verapamil or diltiazem) should be considered in patients who are intolerant or have contraindications to beta-blockers 4, 5
  • If beta-blockers alone are ineffective, disopyramide may be added to improve symptoms by reducing outflow tract gradients 5, 6

Management of Specific Complications

  • Prompt restoration of sinus rhythm or appropriate rate control is essential in patients with new-onset or poorly controlled atrial fibrillation, as it can exacerbate symptoms 4, 5
  • Patients with biventricular hypertrophy may have poor tolerance of atrial fibrillation due to greater dependency on atrial systole for ventricular filling 2, 7
  • Heart failure is the most common presenting symptom in certain forms of biventricular hypertrophy, such as Barth syndrome, and standard heart failure management should be implemented 1, 5

Invasive Treatment Options

  • For left ventricular obstruction, extended septal myectomy via a transaortic approach is the standard surgical procedure 6
  • Concomitant mitral valve surgery may be required in 11-20% of patients undergoing myectomy 6
  • Septal alcohol ablation is an alternative to surgery in selected patients, but requires careful patient selection and experienced centers 6

Risk Factor Modification

  • Intensive management of cardiometabolic risk factors is essential, as obesity, hypertension, diabetes, and sleep apnea are highly prevalent in patients with hypertrophic cardiomyopathy and associated with poorer prognosis 2, 8

Follow-up and Monitoring

  • Regular cardiac evaluation is warranted regardless of neurological status in patients with certain conditions like Friedreich's ataxia 1
  • Monitoring should include assessment of symptom progression, cardiac function, and arrhythmia surveillance 1, 4

Prognosis and Outcomes

  • Treatment-induced regression of left ventricular hypertrophy is independently associated with reduction in major cardiovascular events, stroke, and mortality 9

REFERENCES

9

Treatment of Left Ventricular Hypertrophy [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025